The project focuses on increasing the diversity of genetic data and improving outcomes of conditions such as hypertension, diabetes, and triple-negative breast cancer.
As next-generation antibody-drug conjugates reshape cancer care, digital pathology and artificial intelligence are transforming how HER2 is measured. The advances aim to help clinicians identify low ...
On the latest developments and research in cancer care, busting stress to protect health, advances in reproductive health, in-country innovations, and more ...